GERN (Geron Corporation) Stock Financials & Earnings | Market Cap Arena

GERN (Geron Corporation) Stock Financials & Earnings | Market Cap Arena

GERNGeron Corporation

Mkt Cap$1B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$184M

Net Income (TTM)-$86M

EPS (TTM)-$0.13

Free Cash Flow (TTM)-$111M

Gross Margin86.0%

Op. Margin-29.3%

Net Margin-46.7%

FCF Margin-60.4%

P/S Ratio (TTM)5.7x

P/E Ratio (TTM)—

YoY Rev Growth+138.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$21K	$21K	-$40M
Q2 23	$29K	$29K	-$52M
Q3 23	$164K	$164K	-$48M
Q4 23	$23K	$23K	-$54M
Q1 24	$304K	$304K	-$56M
Q2 24	$882K	$865K	-$69M
Q3 24	$28M	$28M	-$28M
Q4 24	$48M	$47M	-$20M
Q1 25	$40M	$38M	-$17M
Q2 25	$49M	$48M	-$12M
Q3 25	$47M	$25M	-$14M
Q4 25	$48M	$47M	-$11M

Valuation

Quarter	P/S	P/E
Q1 23	2108.4x	—
Q2 23	2314.5x	—
Q3 23	3285.6x	—
Q4 23	4394.6x	—
Q1 24	2002.9x	—
Q2 24	758.6x	—
Q3 24	35.3x	—
Q4 24	13.5x	—
Q1 25	9.0x	—
Q2 25	6.3x	—
Q3 25	5.7x	—
Q4 25	5.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$46M	-$47M
Q2 23	-$30M	-$30M
Q3 23	-$51M	-$51M
Q4 23	-$41M	-$41M
Q1 24	-$62M	-$63M
Q2 24	-$53M	-$54M
Q3 24	-$59M	-$59M
Q4 24	-$44M	-$44M
Q1 25	-$48M	-$48M
Q2 25	-$27M	-$28M
Q3 25	-$14M	-$13M
Q4 25	-$22M	-$22M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$372K
Q2 23	$202K
Q3 23	$192K
Q4 23	$64K
Q1 24	$615K
Q2 24	$206K
Q3 24	$0
Q4 24	$141K
Q1 25	$0
Q2 25	$138K
Q3 25	$89K
Q4 25	$32K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-82.9%	+39.3%
Q2 23	-60.3%	+85.3%
Q3 23	-44.8%	+18.7%
Q4 23	-77.7%	+29.1%
Q1 24	+1347.6%	+40.7%
Q2 24	+2941.4%	+35.1%
Q3 24	+17138.4%	+18.2%
Q4 24	+206582.6%	+24.4%
Q1 25	+12927.3%	-0.2%
Q2 25	+5459.6%	-12.4%
Q3 25	+67.1%	+8.2%
Q4 25	+1.0%	-13.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	14100.0%
Q2 23	$4M	13944.8%
Q3 23	$8M	4660.4%
Q4 23	$0	0.0%
Q1 24	$5M	1634.5%
Q2 24	$13M	1433.1%
Q3 24	$7M	24.4%
Q4 24	$7M	14.3%
Q1 25	$7M	18.7%
Q2 25	-$7M	-15.1%
Q3 25	$7M	14.3%
Q4 25	$7M	15.5%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$27M	$13M	—
Q2 23	$35M	$16M	—
Q3 23	$29M	$18M	—
Q4 23	$33M	$21M	—
Q1 24	$29M	$27M	—
Q2 24	$31M	$39M	—
Q3 24	$20M	$36M	—
Q4 24	$23M	$43M	—
Q1 25	$15M	$40M	—
Q2 25	$22M	—	$39M
Q3 25	$21M	—	$39M
Q4 25	$16M	—	$42M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$113M	$268M	$381M
Q2 23	$57M	$314M	$371M
Q3 23	$31M	$283M	$314M
Q4 23	$71M	$264M	$335M
Q1 24	$190M	$253M	$443M
Q2 24	$117M	$246M	$363M
Q3 24	$60M	$279M	$340M
Q4 24	$79M	$328M	$407M
Q1 25	$84M	$313M	$397M
Q2 25	$78M	$310M	$388M
Q3 25	$78M	$302M	$381M
Q4 25	$79M	$280M	$360M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	544M	+33.4%
Q2 23	547M	+0.5%
Q3 23	580M	+5.9%
Q4 23	595M	+2.7%
Q1 24	603M	+1.4%
Q2 24	654M	+8.4%
Q3 24	662M	+1.3%
Q4 24	646M	-2.4%
Q1 25	666M	+3.1%
Q2 25	666M	+0.0%
Q3 25	667M	+0.1%
Q4 25	667M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$27K	42
FY 15	$2M	17
FY 16	$411K	15
FY 17	$71K	15
FY 18	$63K	17
FY 19	$10K	45
FY 20	$5K	53
FY 21	$20K	69
FY 22	$6K	107
FY 23	$2K	141
FY 24	$336K	229
FY 25	$3K	64K